Home Medicine A novel OTX2 gene frameshift mutation in a child with microphthalmia, ectopic pituitary and growth hormone deficiency
Article
Licensed
Unlicensed Requires Authentication

A novel OTX2 gene frameshift mutation in a child with microphthalmia, ectopic pituitary and growth hormone deficiency

  • Antonella Lonero , Maurizio Delvecchio EMAIL logo , Paola Primignani , Roberto Caputo , Sara Bargiacchi , Silvana Penco , Lucia Mauri , Elena Andreucci , Maria Felicia Faienza and Luciano Cavallo
Published/Copyright: March 12, 2016

Abstract

OTX2 mutations are reported in patients with eye maldevelopment and in some cases with brain or pituitary abnormalities. We describe a child carrying a novel OTX2 heterozygous mutation. She presented microphthalmia, absence of retinal vascularization, vitreal spots and optic nerve hypoplasia in the right eye and mild macular dystrophy in the left eye. Midline brain structures and cerebral parenchyma were normal, except for the ectopic posterior pituitary gland. OTX2 sequencing showed a heterozygous c.402del mutation. Most of OTX2 mutations are nonsense or frameshift introducing a premature termination codon and resulting in a truncated protein. More rarely missense mutations occur. Our novel OTX2 mutation (c.402del) is a frameshift mutation (p.S135Lfs*43), never reported before, causing a premature codon stop 43 amino-acids downstream, which is predicted to generate a premature truncation. The mutation was associated with microphthalmia and ectopic posterior pituitary.


Corresponding author: Maurizio Delvecchio, MD, PhD, Department of Biomedical Sciences and Human Oncology, AOU Policlinico Giovanni XXIII Bari – 70126 Bari, Italy, Phone: +39 080 5593580, Fax: +39 080 5592287, E-mail:

References

1. Spieler D, Bäumer N, Stebler J, Köprunner M, Reichman-Fried M, et al. Involvement of Pax6 and Otx2 in the forebrain-specific regulation of the vertebrate homeobox gene ANF/Hesx1. Dev Biol 2004;15:269:567–79.10.1016/j.ydbio.2004.01.044Search in Google Scholar PubMed

2. Ragge NK, Brown AG, Poloschek CM, Lorenz B, Henderson RA, et al. Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet 2005;76:1008–22.10.1086/430721Search in Google Scholar PubMed PubMed Central

3. Schilter K, Schneider A, Bardakjian T, Soucy JF, Tyler RC, et al. OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype. Clin Genet 2011;79:158–68.10.1111/j.1399-0004.2010.01450.xSearch in Google Scholar PubMed PubMed Central

4. Mauri L, Franzoni A, Scarcello M, Sala S, Garavelli L, et al. SOX2, OTX2 and PAX6 analysis in subjects with anophthalmia and microphthalmia. Eur J Med Genet 2015;58:66–70.10.1016/j.ejmg.2014.12.005Search in Google Scholar PubMed

5. Antonini SR, Grecco Filho A, Elias LL, Moreira AC, Castro M. Cerebral midline developmental anomalies: endocrine, neuroradiographic and ophthalmological features. J Pediatr Endocrinol Metab 2002:15:1525–30.10.1515/JPEM.2002.15.9.1525Search in Google Scholar

6. Haddad NG, Eugster EA. Hypopituitarism and neurodevelopmental abnormalities in relation to central nervous system structural defects in children with optic nerve hypoplasia. J Pediatr Endocrinol Metab 2005:18:853–8.10.1515/JPEM.2005.18.9.853Search in Google Scholar

7. Traggiai C, Stanhope R. Body mass index and hypothalamic morphology on MRI in children with congenital midline cerebral abnormalities. J Pediatr Endocrinol Metab 2004:17:219–21.10.1515/JPEM.2004.17.2.219Search in Google Scholar PubMed

8. Kelley CG, Lavorgna G, Clark M, Boncinelli E, Mellon PL. The Otx2 homeoprotein regulates expression from the gonadotropin-releasing hormone proximal promoter. Molec Endocr 2000;14:1246–56.10.1210/mend.14.8.0509Search in Google Scholar PubMed

9. Dateki S, Fukami M, Sato N, Muroya K, Adachi M, et al. OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters. J Clin Endocrinol Metab 2008;93:3697–702.10.1210/jc.2008-0720Search in Google Scholar PubMed

10. Dateki S, Kosaka K, Hasegawa K, Tanaka H, Azuma N, et al. Heterozygous orthodenticle homeobox 2 mutations are associated with variable pituitary phenotype. J Clin Endocrin Metab 2010;95:756–64.10.1210/jc.2009-1334Search in Google Scholar PubMed

11. Del Blanco DG, Romero CJ, Diaczok D, de Graaff LC, Radovick S, et al. Eur J Endocrinol 2012:167:441–52.10.1530/EJE-12-0333Search in Google Scholar PubMed

Received: 2015-10-28
Accepted: 2016-1-22
Published Online: 2016-3-12
Published in Print: 2016-5-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Resistance to thyroid hormone α, revelation of basic study to clinical consequences
  4. Original Articles
  5. Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach
  6. Safety and metabolic impact of Ramadan fasting in children and adolescents with type 1 diabetes
  7. Waist-to-height ratio as a marker of low-grade inflammation in obese children and adolescents
  8. Classification and clinical characterization of metabolically “healthy” obese children and adolescents
  9. Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia – effect on median Phe/Tyr ratios
  10. Compound heterozygous mutations (p.T561M and c.2422delT) in the TPO gene associated with congenital hypothyroidism
  11. Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency
  12. Urate crystals deposition in the feet of overweight juveniles and those with symptomatic hyperuricemia: a dual-energy CT study
  13. A novel ALMS1 homozygous mutation in two Turkish brothers with Alström syndrome
  14. Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family
  15. Pituitary gigantism: a retrospective case series
  16. Case Reports
  17. A novel OTX2 gene frameshift mutation in a child with microphthalmia, ectopic pituitary and growth hormone deficiency
  18. A novel nonsense mutation in the WFS1 gene causes the Wolfram syndrome
  19. A 33-year-old male patient with paternal derived duplication of 14q11.2–14q22.1~22.3: clinical course, phenotypic and genotypic findings
  20. Familial Turner syndrome: the importance of information
  21. De novo mutation of PHEX in a type 1 diabetes patient
  22. Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase
Downloaded on 18.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0425/html
Scroll to top button